The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial

被引：0
|
作者：
Karen E. Hoffman
Stephanie L. Pugh
Jennifer L. James
Charles Scarantino
Benjamin Movsas
Richard K. Valicenti
Andre Fortin
JonDavid Pollock
Harold Kim
David G. Brachman
Lawrence B. Berk
Deborah Watkins Bruner
Lisa A. Kachnic
机构：
[1] University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[2] RTOG Statistical Center,The Schiffler Cancer Center
[3] Rex Cancer Center,Karamanos Cancer Institute
[4] Henry Ford Health System,undefined
[5] University of California Davis,undefined
[6] L’ Hotel-Dieu de Quebec,undefined
[7] Wheeling Hospital,undefined
[8] Wayne State University,undefined
[9] Arizona Oncology Services Foundation,undefined
[10] H. Lee Moffitt Cancer Center,undefined
[11] University of Pennsylvania School of Nursing,undefined
[12] Boston Medical Center MBCCOP,undefined
来源：
Quality of Life Research | 2014年 / 23卷
关键词：
GM-CSF; Head and neck cancer; Quality of life; Radiation mucositis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1841 / 1858
页数：17
相关论文
共 39 条
  • [1] The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial
    Hoffman, Karen E.
    Pugh, Stephanie L.
    James, Jennifer L.
    Scarantino, Charles
    Movsas, Benjamin
    Valicenti, Richard K.
    Fortin, Andre
    Pollock, JonDavid
    Kim, Harold
    Brachman, David G.
    Berk, Lawrence B.
    Bruner, Deborah Watkins
    Kachnic, Lisa A.
    QUALITY OF LIFE RESEARCH, 2014, 23 (06) : 1841 - 1858
  • [2] The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: A double-blind placebo-controlled prospective phase III study by radiation therapy oncology group 9901
    Ryu, Janice K.
    Swann, Suzanne
    LeVeque, Francis
    Scarantino, Charles W.
    Johnson, Darlene
    Chen, Allan
    Fortin, Andre
    Pollock, JonDavid
    Kim, Harold
    Ang, Kian K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (03): : 643 - 650
  • [3] A randomized clinical trial of granulocyte macrophage colony stimulating factor mouthwash for oral mucositis in head and neck cancer
    Dodd, Marylin J.
    Cho, Maria H.
    Cooper, Bruce A.
    MacPhail, Laurie
    Miaskowski, Christine
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2022, 56
  • [4] A randomized clinical trial of granulocyte macrophage colony stimulating factor mouthwash for oral mucositis in head and neck cancer
    Dodd, Marylin J.
    Cho, Maria H.
    Cooper, Bruce A.
    MacPhail, Laurie
    Miaskowski, Christine
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2022, 56
  • [5] Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous-head and neck cancer
    Su, Yungpo Bernard
    Vickers, Andrew J.
    Zelefsky, Michael J.
    Kraus, Dennis H.
    Shaha, Ashok R.
    Shah, Jatin P.
    Serio, Angel M.
    Harrison, Louis B.
    Bosl, George J.
    Pfister, David G.
    CANCER JOURNAL, 2006, 12 (03) : 182 - 188
  • [6] A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report
    Nicolatou, O
    Sotiropoulou-Lontou, A
    Skarlatos, J
    Kyprianou, K
    Kolitsi, G
    Dardoufas, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (03): : 551 - 556
  • [7] Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia A Randomized, Double-Blind, Placebo-controlled Trial
    Criner, Gerard J.
    Lang, Frederick M.
    Gottlieb, Robert L.
    Mathews, Kusum S.
    Wang, Tisha S.
    Rice, Todd W.
    Madduri, Deepu
    Bellam, Shashi
    Jeanfreau, Robert
    Case, Amy H.
    Glassberg, Marilyn K.
    Lyon, George Marshall
    Ahmad, Kareem
    Mendelson, Robert
    DiMaio, J. Michael
    Tran, MaryAnn P.
    Spak, Cedric W.
    Abbasi, Jamil A.
    Davis, Steven G.
    Ghamande, Shekhar
    Shen, Steven
    Sherman, Lisa
    Lowry, Simon
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (11) : 1290 - 1299
  • [8] Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin
    Yau, JC
    Neidhart, JA
    Triozzi, P
    Verma, S
    Nemunaitis, J
    Quick, DP
    Mayernik, DG
    Oette, DH
    Hayes, FA
    Holcenberg, J
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 51 (04) : 289 - 295
  • [9] Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer
    Lalla, Rajesh V.
    Choquette, Linda E.
    Curley, Kathleen F.
    Dowsett, Robert J.
    Feinn, Richard S.
    Hegde, Upendra P.
    Pilbeam, Carol C.
    Salner, Andrew L.
    Sonis, Stephen T.
    Peterson, Douglas E.
    ORAL ONCOLOGY, 2014, 50 (11) : 1098 - 1103
  • [10] Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial
    Vacheron, Charles-Herve
    Lepape, Alain
    Venet, Fabienne
    Monneret, Guillaume
    Gueyffier, Francois
    Boutitie, Florent
    Vallin, Helene
    Schwebel, Carole
    Maucort-Boulch, Delphine
    Friggeri, Arnaud
    JOURNAL OF CRITICAL CARE, 2023, 78
1234